BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang JT, Wang TH, Sheu JC, Shih LN, Lin JT, Chen DS. Detection of hepatitis B virus DNA by polymerase chain reaction in plasma of volunteer blood donors negative for hepatitis B surface antigen. J Infect Dis. 1991;163:397-399. [PMID: 1988524 DOI: 10.1093/infdis/163.2.397] [Cited by in Crossref: 103] [Cited by in F6Publishing: 104] [Article Influence: 3.4] [Reference Citation Analysis]
Number Citing Articles
1 Coursaget P, Le Cann P, Leboulleux D, Diop MT, Bao O, Coll AM. Detection of hepatitis B virus DNA by polymerase chain reaction in HBsAg negative Senegalese patients suffering from cirrhosis or primary liver cancer. FEMS Microbiol Lett. 1991;67:35-38. [PMID: 1778420 DOI: 10.1111/j.1574-6968.1991.tb04384.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.5] [Reference Citation Analysis]
2 Pei SN, Chen CH. Risk and prophylaxis strategy of hepatitis B virus reactivation in patients with lymphoma undergoing chemotherapy with or without rituximab. Leuk Lymphoma 2015;56:1611-8. [PMID: 25248874 DOI: 10.3109/10428194.2014.964699] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
3 Motta JS, Mello FC, Lago BV, Perez RM, Gomes SA, Figueiredo FF. Occult hepatitis B virus infection and lamivudine-resistant mutations in isolates from renal patients undergoing hemodialysis. J Gastroenterol Hepatol. 2010;25:101-106. [PMID: 19817965 DOI: 10.1111/j.1440-1746.2009.05972.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 2.3] [Reference Citation Analysis]
4 Akcam FZ, Kocak N, Demir C. Acute hepatitis B infection due to erythrocyte suspension obtained from 'anti-HBc alone' positive donor. Transfus Med 2005;15:61-2. [PMID: 15713131 DOI: 10.1111/j.1365-3148.2005.00551.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
5 Almeida RP, Cardoso DD. Detection of HBV DNA by nested-PCR in a HBsAg and anti-HBc negative blood bank donor. J Clin Virol 2006;36:231-4. [PMID: 16574475 DOI: 10.1016/j.jcv.2006.02.004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
6 Hwang SJ, Lu RH, Wood ML, Wang YJ, Chang FY, Lee SD. Comparison of the nucleic acid-based crosslinking hybridization assay and the branched DNA signal amplification assay in the quantitative measurement of serum hepatitis B virus DNA. J Clin Lab Anal. 1999;13:296-300. [PMID: 10633298 DOI: 10.1002/(sici)1098-2825(1999)13:6<296::aid-jcla8>3.0.co;2-c] [Reference Citation Analysis]
7 Wang JT, Lin JT, Sheu JC, Yang JC, Chen DS, Wang TH. Detection ofHelicobacter pylori in gastric biopsy tissue by polymerase chain reaction. Eur J Clin Microbiol Infect Dis 1993;12:367-71. [DOI: 10.1007/bf01964436] [Cited by in Crossref: 33] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
8 Rysgaard CD, Morris CS, Drees D, Bebber T, Davis SR, Kulhavy J, Krasowski MD. Positive hepatitis B surface antigen tests due to recent vaccination: a persistent problem. BMC Clin Pathol 2012;12:15. [PMID: 23006828 DOI: 10.1186/1472-6890-12-15] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
9 Busch M. Prevention of Transmission of Hepatitis B, Hepatitis C and Human Immunodeficiency Virus Infections Through Blood Transfusion by Anti-HBc Testing. Vox Sanguinis 1998;74:147-54. [DOI: 10.1111/j.1423-0410.1998.tb05413.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
10 Arraes LC, Ximenes R, Andrieu JM, Lu W, Barreto S, Pereira LM, Castelo A. The biological meaning of anti-HBC positive result in blood donors: relation to HBV-DNA and to other serological markers. Rev Inst Med Trop Sao Paulo 2003;45:137-40. [PMID: 12870062 DOI: 10.1590/s0036-46652003000300004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
11 Raimondo G, Balsano C, Craxì A, Farinati F, Levrero M, Mondelli M, Pollicino T, Squadrito G, Tiribelli C. Occult hepatitis B virus infection. Digestive and Liver Disease 2000;32:822-6. [DOI: 10.1016/s1590-8658(00)80362-x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
12 Saraswat S, Banerjee K, Chaudhury N, Mahant T, Khandekar P, Gupta RK, Naik S. Post-transfusion hepatitis type B following multiple transfusions of HBsAg-negative blood. J Hepatol. 1996;25:639-643. [PMID: 8938539 DOI: 10.1016/s0168-8278(96)80232-7] [Cited by in Crossref: 42] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
13 Kim SM, Lee KS, Park CJ, Lee JY, Kim KH, Park JY, Lee JH, Kim HY, Yoo JY, Jang MK. Prevalence of occult HBV infection among subjects with normal serum ALT levels in Korea. J Infect. 2007;54:185-191. [PMID: 16564573 DOI: 10.1016/j.jinf.2006.02.002] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 2.2] [Reference Citation Analysis]
14 Thiers V, Lunel F, Valla D, Azar N, Fretz C, Frangeul L, Huraux J, Opolon P, Brechot C. Post-transfusional anti-HCV-negative non-A non-B hepatitis (II) serological and polymerase chain reaction analysis for hepatitis C and hepatitis B viruses. Journal of Hepatology 1993;18:34-9. [DOI: 10.1016/s0168-8278(05)80007-8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 1] [Article Influence: 0.9] [Reference Citation Analysis]
15 Chabaud M, Depril N, Le Cann P, Leboulleux D, Nandi R, Coll-Seck AM, Coursaget P. Detection of hepatitis B virus DNA by polymerase chain reaction in vaccinated and non-vaccinated Senegalese children. Arch Virol Suppl 1993;8:123-31. [PMID: 7505143 DOI: 10.1007/978-3-7091-9312-9_13] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Fabris P, Brown D, Tositti G, Bozzola L, Giordani MT, Bevilacqua P, de Lalla F, Webster GJ, Dusheiko G. Occult hepatitis B virus infection does not affect liver histology or response to therapy with interferon alpha and ribavirin in intravenous drug users with chronic hepatitis C. J Clin Virol. 2004;29:160-166. [PMID: 14962784 DOI: 10.1016/s1386-6532(03)00117-3] [Cited by in Crossref: 42] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
17 Mortensen E, Kamali A, Schirmer PL, Lucero-Obusan C, Winston CA, Oda G, Winters MA, Durfee J, Martinello RA, Davey VJ, Holodniy M. Are current screening protocols for chronic hepatitis B virus infection adequate? Diagn Microbiol Infect Dis 2016;85:159-67. [PMID: 27009896 DOI: 10.1016/j.diagmicrobio.2015.12.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
18 Ikeda K, Kobayashi M, Someya T, Saitoh S, Hosaka T, Akuta N, Suzuki F, Suzuki Y, Arase Y, Kumada H. Occult hepatitis B virus infection increases hepatocellular carcinogenesis by eight times in patients with non-B, non-C liver cirrhosis: a cohort study. J Viral Hepat. 2009;16:437-443. [PMID: 19226331 DOI: 10.1111/j.1365-2893.2009.01085.x] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 4.2] [Reference Citation Analysis]
19 Schattner A, Leitner M, Keysary A, Geltner D. Case Report: Fatal Seronegative Rickettsial Infection Diagnosed by the Polymerase Chain Reaction. The American Journal of the Medical Sciences 1992;303:392-4. [DOI: 10.1097/00000441-199206000-00007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
20 Hassan ZK, Hafez MM, Mansor TM, Zekri AR. Occult HBV infection among Egyptian hepatocellular carcinoma patients. Virol J. 2011;8:90. [PMID: 21371325 DOI: 10.1186/1743-422x-8-90] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
21 Allain JP. Occult hepatitis B virus infection: implications in transfusion. Vox Sang. 2004;86:83-91. [PMID: 15023176 DOI: 10.1111/j.0042-9007.2004.00406.x] [Cited by in Crossref: 192] [Cited by in F6Publishing: 182] [Article Influence: 11.3] [Reference Citation Analysis]
22 Sánchez-Quijano A, Jauregui JI, Leal M, Pineda JA, Castilla A, Abad MA, Civeira MP, García de Pesquera F, Prieto J, Lissen E. Hepatitis B virus occult infection in subjects with persistent isolated anti-HBc reactivity. J Hepatol. 1993;17:288-293. [PMID: 8315257 DOI: 10.1016/s0168-8278(05)80207-7] [Cited by in Crossref: 38] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
23 Matsumoto C, Nishioka K, Oguchi T, Mitsunaga S, Nojiri N, Tadokoro K, Juji T. Detection and quantitation of HBV DNA by semi-nested PCR in donated blood: comparison with HBV serological markers. Journal of Virological Methods 1997;66:61-9. [DOI: 10.1016/s0166-0934(97)00037-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
24 Feitelson MA, Duan L, Guo J, Horiike N, Mcintyre G, Blumberg BS, Thomas HC, Carman W. Precore and X region mutants in hepatitis B virus infections among renal dialysis patients. J Viral Hepat 1995;2:19-31. [DOI: 10.1111/j.1365-2893.1995.tb00068.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
25 Aguiar JI, Aguiar E, Paniago A, Cunha R, Galvão L, Daher R. Prevalence of antibodies to hepatitis B core antigen in blood donors in the middle West region of Brazil. Mem Inst Oswaldo Cruz 2001;96:185-7. [PMID: 11285495 DOI: 10.1590/s0074-02762001000200009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
26 Minuk GY, Sun DF, Uhanova J, Zhang M, Caouette S, Nicolle LE, Gutkin A, Doucette K, Martin B, Giulivi A. Occult hepatitis B virus infection in a North American community-based population. J Hepatol. 2005;42:480-485. [PMID: 15763333 DOI: 10.1016/j.jhep.2004.11.037] [Cited by in Crossref: 65] [Cited by in F6Publishing: 62] [Article Influence: 4.1] [Reference Citation Analysis]
27 Pinho JR, Santos CA, Gonzalez CL, Bassit L, Barreto CC, Saez-Alquezar A, França AV, Carrilho FJ, Fonseca LE, Chamone DA. Detection of hepatitis B virus DNA by the polymerase chain reaction in anti-HBe positive chronic hepatitis B patients. Rev Inst Med Trop Sao Paulo 1993;35:515-20. [PMID: 7997755 DOI: 10.1590/s0036-46651993000600007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
28 Gutiérrez C, León G, Loureiro CL, Uzcátegui N, Liprandi F, Pujol FH. Hepatitis B Virus DNA in Blood Samples Positive for Antibodies to Core Antigen and Negative for Surface Antigen. Clin Diagn Lab Immunol 1999;6:768-70. [DOI: 10.1128/cdli.6.5.768-770.1999] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
29 Ameen R, Sanad N, Al-Shemmari S, Siddique I, Chowdhury RI, Al-Hamdan S, Al-Bashir A. Prevalence of viral markers among first-time Arab blood donors in Kuwait. Transfusion. 2005;45:1973-1980. [PMID: 16371052 DOI: 10.1111/j.1537-2995.2005.00635.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 2.3] [Reference Citation Analysis]
30 Rasenack J, Schlayer H, Hettler F, Peters T, Preisler-adams S, Gerok W. Hepatitis B virus infection without immunological markers after open-heart surgery. The Lancet 1995;345:355-7. [DOI: 10.1016/s0140-6736(95)90342-9] [Cited by in Crossref: 14] [Article Influence: 0.5] [Reference Citation Analysis]
31 Fujiwara K, Tanaka Y, Orito E, Ohno T, Kato T, Sugauchi F, Suzuki S, Hattori Y, Sakurai M, Hasegawa I, Ozasa T, Kanie F, Kano H, Ueda R, Mizokami M. Lack of association between occult hepatitis B virus DNA viral load and aminotransferase levels in patients with hepatitis C virus-related chronic liver disease. J Gastroenterol Hepatol 2004;19:1343-7. [DOI: 10.1111/j.1440-1746.2004.03439.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
32 Nalpas B, Feitelson M, Brechot C, Rubin E. Alcohol, Hepatotropic Viruses, and Hepatocellular Carcinoma. Alcoholism Clin Exp Res 1995;19:1089-95. [DOI: 10.1111/j.1530-0277.1995.tb01585.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
33 Allain J. Occult hepatitis B virus infection. Transfusion Clinique et Biologique 2004;11:18-25. [DOI: 10.1016/j.tracli.2003.11.007] [Cited by in Crossref: 92] [Cited by in F6Publishing: 89] [Article Influence: 5.4] [Reference Citation Analysis]
34 Bhattacharya P, Chandra PK, Datta S, Banerjee A, Chakraborty S, Rajendran K, Basu SK, Bhattacharya SK, Chakravarty R. Significant increase in HBV, HCV, HIV and syphilis infections among blood donors in West Bengal, Eastern India 2004-2005: exploratory screening reveals high frequency of occult HBV infection. World J Gastroenterol. 2007;13:3730-3733. [PMID: 17659734 DOI: 10.3748/wjg.v13.i27.3730] [Cited by in CrossRef: 43] [Cited by in F6Publishing: 46] [Article Influence: 3.1] [Reference Citation Analysis]
35 Abbasi S, Makvandi M, Karimi G, Neisi N. The Prevalence of SEN Virus and Occult Hepatitis B (OBI) Virus Infection Among Blood Donors in Ahvaz City. Jundishapur J Microbiol 2016;9:e37329. [PMID: 27679708 DOI: 10.5812/jjm.37329] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
36 Kumari S. Prevalence and trends of hepatitis B virus, Hepatitis C virus, Human immunodeficiency virus 1, 2 and syphilis infections among blood donors in a regional transfusion center in Punjab, India: A 3 years study. Indian J Sex Transm Dis AIDS 2020;41:22-9. [PMID: 33062977 DOI: 10.4103/0253-7184.196887] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
37 Wang JT, Wang TH, Sheu JC, Lin JT, Chen DS. Hepatitis C virus RNA in saliva of patients with posttransfusion hepatitis and low efficiency of transmission among spouses. J Med Virol. 1992;36:28-31. [PMID: 1315367 DOI: 10.1002/jmv.1890360106] [Cited by in Crossref: 56] [Cited by in F6Publishing: 50] [Article Influence: 1.9] [Reference Citation Analysis]
38 Nalpas B, Pol S, Thépot V, Berthelot P, Brechot C. Hepatocellular carcinoma in alcoholics. Alcohol 1995;12:117-20. [PMID: 7772261 DOI: 10.1016/0741-8329(94)00092-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
39 Greer S, Alexander GJ. Viral serology and detection. Baillieres Clin Gastroenterol 1995;9:689-721. [PMID: 8903801 DOI: 10.1016/0950-3528(95)90057-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
40 Hofer M, Joller-Jemelka HI, Grob PJ, Lüthy R, Opravil M. Frequent chronic hepatitis B virus infection in HIV-infected patients positive for antibody to hepatitis B core antigen only. Swiss HIV Cohort Study. Eur J Clin Microbiol Infect Dis. 1998;17:6-13. [PMID: 9512175 DOI: 10.1007/bf01584356] [Cited by in Crossref: 133] [Cited by in F6Publishing: 46] [Article Influence: 5.8] [Reference Citation Analysis]
41 Li L, Chen PJ, Chen MH, Chak KF, Lin KS, Tsai SJ. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus. Transfusion 2008;48:1198-206. [PMID: 18422856 DOI: 10.1111/j.1537-2995.2008.01672.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 3.2] [Reference Citation Analysis]
42 Wang Q, Klenerman P, Semmo N. Significance of anti-HBc alone serological status in clinical practice. The Lancet Gastroenterology & Hepatology 2017;2:123-34. [DOI: 10.1016/s2468-1253(16)30076-0] [Cited by in Crossref: 21] [Cited by in F6Publishing: 3] [Article Influence: 5.3] [Reference Citation Analysis]
43 Zanetti AR, Romanò L, Zappá A, Velati C. Changing patterns of hepatitis B infection in Italy and NAT testing for improving the safety of blood supply. Journal of Clinical Virology 2006;36:S51-5. [DOI: 10.1016/s1386-6532(06)80009-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
44 Tong MJ, Hwang S, Lefkowitz M, Lee S, Co RL, Lo K. A pilot, open-labelled, phase II study using oral ribavirin in the treatment of patients with chronic active hepatitis B. Clinical and Diagnostic Virology 1995;3:377-85. [DOI: 10.1016/0928-0197(94)00051-u] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
45 He Z, Zhuang H, Wang X, Song S, Dong Q, Yan J, Buehring GC, Luo G. Retrospective analysis of non-A-E hepatitis: possible role of hepatitis B and C virus infection. J Med Virol 2003;69:59-65. [PMID: 12436478 DOI: 10.1002/jmv.10248] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
46 Hwang SJ, Lu RH, Wood ML, Wang YJ, Chang FY, Lee SD. Comparison of the nucleic acid-based crosslinking hybridization assay and the branched DNA signal amplification assay in the quantitative measurement of serum hepatitis B virus DNA. J Clin Lab Anal 1999;13:296-300. [PMID: 10633298 DOI: 10.1002/(sici)1098-2825(1999)13:6<296::aid-jcla8>3.0.co;2-c] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
47 Wang JT, Lee CZ, Kao JH, Sheu JC, Wang TH, Chen DS. Incidence and clinical presentation of posttransfusion TT virus infection in prospectively followed transfusion recipients: emphasis on its relevance to hepatitis. Transfusion. 2000;40:596-601. [PMID: 10827266 DOI: 10.1046/j.1537-2995.2000.40050596.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
48 Kazemi-Shirazi L, Petermann D, Müller C. Hepatitis B virus DNA in sera and liver tissue of HBsAg negative patients with chronic hepatitis C. J Hepatol. 2000;33:785-790. [PMID: 11097488 DOI: 10.1016/s0168-8278(00)80311-6] [Cited by in Crossref: 58] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
49 Liu CJ, Lo SC, Kao JH, Tseng PT, Lai MY, Ni YH, Yeh SH, Chen PJ, Chen DS. Transmission of occult hepatitis B virus by transfusion to adult and pediatric recipients in Taiwan. J Hepatol. 2006;44:39-46. [PMID: 16168517 DOI: 10.1016/j.jhep.2005.06.016] [Cited by in Crossref: 81] [Cited by in F6Publishing: 74] [Article Influence: 5.1] [Reference Citation Analysis]
50 de la Fuente RA, Gutiérrez ML, Garcia-Samaniego J, Fernández-Rodriguez C, Lledó JL, Castellano G. Pathogenesis of occult chronic hepatitis B virus infection. World J Gastroenterol. 2011;17:1543-1548. [PMID: 21472118 DOI: 10.3748/wjg.v17.i12.1543] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
51 Ozkan S, Atak A, Bozdayi G, Turkcuoglu S, Maral I. Community-based research: cost of the tests used for anti-HBc total seropositivity only and hepatitis B screening. Transactions of the Royal Society of Tropical Medicine and Hygiene 2010;104:782-6. [DOI: 10.1016/j.trstmh.2010.08.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
52 Nna E, Mbamalu C, Ekejindu I. Occult hepatitis B viral infection among blood donors in South-Eastern Nigeria. Pathog Glob Health 2014;108:223-8. [PMID: 24995918 DOI: 10.1179/2047773214Y.0000000144] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
53 Liu C, Chen D, Chen P. Epidemiology of HBV infection in Asian blood donors: Emphasis on occult HBV infection and the role of NAT. Journal of Clinical Virology 2006;36:S33-44. [DOI: 10.1016/s1386-6532(06)80007-7] [Cited by in Crossref: 72] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
54 Weber B, Bayer A, Kirch P, Schlüter V, Schlieper D, Melchior W. Improved Detection of Hepatitis B Virus Surface Antigen by a New Rapid Automated Assay. J Clin Microbiol 1999;37:2639-47. [DOI: 10.1128/jcm.37.8.2639-2647.1999] [Cited by in Crossref: 38] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
55 Peters SE, Wakefield AE, Banerji S, Hopkin JM. Quantification of the detection of Pneumocystis carinii by DNA amplification. Mol Cell Probes 1992;6:115-7. [PMID: 1513340 DOI: 10.1016/0890-8508(92)90055-3] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 0.8] [Reference Citation Analysis]
56 Bart PA, Jacquier P, Zuber PL, Lavanchy D, Frei PC. Seroprevalence of HBV (anti-HBc, HBsAg and anti-HBs) and HDV infections among 9006 women at delivery. Liver 1996;16:110-6. [PMID: 8740844 DOI: 10.1111/j.1600-0676.1996.tb00714.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
57 Hung WL, Wu JF, Ni YH, Chen HL, Chiang CL, Chang MH, Hsu HY. Occult hepatitis B virus and surface antigen mutant infection in healthy vaccinated cohorts and children with various forms of hepatitis and multiple transfusions. Liver Int 2019;39:1052-61. [PMID: 30790411 DOI: 10.1111/liv.14076] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
58 Matsuo T, Shinzawa H, Togashi H, Aoki M, Sugahara K, Saito K, Saito T, Takahashi T, Yamaguchi I, Aoyama M, Kamada H. Highly sensitive hepatitis B surface antigen detection by measuring stable nitroxide radical formation with ESR spectroscopy. Free Radic Biol Med 1998;25:929-35. [PMID: 9840738 DOI: 10.1016/s0891-5849(98)00125-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
59 Raimondo G, Cacciamo G, Saitta C. Hepatitis B virus and hepatitis C virus co-infection: additive players in chronic liver disease? Annals of Hepatology 2005;4:100-6. [DOI: 10.1016/s1665-2681(19)32072-1] [Cited by in Crossref: 23] [Article Influence: 1.4] [Reference Citation Analysis]
60 Kocabaş E, Aksaray N, Alhan E, Tanyeli A, Köksal F, Yarkin F. Hepatitis B and C virus infections in Turkish children with cancer. Eur J Epidemiol 1997;13:869-73. [PMID: 9476814 DOI: 10.1023/a:1007420725704] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
61 Mason A, Yoffe B, Noonan C, Mearns M, Campbell C, Kelley A, Perrillo RP. Hepatitis B virus DNA in peripheral-blood mononuclear cells in chronic hepatitis B after HBsAg clearance. Hepatology 1992;16:36-41. [DOI: 10.1002/hep.1840160108] [Cited by in Crossref: 69] [Cited by in F6Publishing: 69] [Article Influence: 2.4] [Reference Citation Analysis]
62 Keyvani H, Agah S, Kabir A, Alavian S. Prevalence and risk factors of isolated anti-HBc antibody and occult hepatitis B infection in hemodialysis patients: a nationwide study. Annals of Hepatology 2013;12:213-9. [DOI: 10.1016/s1665-2681(19)31359-6] [Cited by in Crossref: 13] [Article Influence: 1.6] [Reference Citation Analysis]
63 Schories M, Peters T, Rasenack J. Isolation, characterization and biological significance of hepatitis B virus mutants from serum of a patient with immunologically negative HBV infection. J Hepatol. 2000;33:799-811. [PMID: 11097490 DOI: 10.1016/s0168-8278(00)80313-x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
64 Seifried E, Roth WK. Optimal blood donation screening: Annotation. British Journal of Haematology 2000;109:694-8. [DOI: 10.1046/j.1365-2141.2000.02100.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
65 Raimondo G. Occult hepatitis B virus infection and liver disease: fact or fiction? Journal of Hepatology 2001;34:471-3. [DOI: 10.1016/s0168-8278(01)00016-2] [Cited by in Crossref: 26] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
66 Pei S, Chen C, Lee C, Wang M, Ma M, Hu T, Kuo C. Reactivation of hepatitis B virus following rituximab-based regimens: a serious complication in both HBsAg-positive and HBsAg-negative patients. Ann Hematol 2010;89:255-62. [DOI: 10.1007/s00277-009-0806-7] [Cited by in Crossref: 148] [Cited by in F6Publishing: 135] [Article Influence: 12.3] [Reference Citation Analysis]
67 Whyte G. Safe transfusion: Perspective from the blood supply agency. Transfusion Science 1994;15:19-25. [DOI: 10.1016/0955-3886(94)90047-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
68 Vitale F, Tramuto F, Orlando A, Vizzini G, Meli V, Cerame G, Mazzucco W, Virdone R, Palazzo U, Villafrate MR. Can the serological status of anti-HBc alone be considered a sentinel marker for detection of occult HBV infection? J Med Virol. 2008;80:577-582. [PMID: 18297707 DOI: 10.1002/jmv.21121] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 3.3] [Reference Citation Analysis]
69 Evens AM, Jovanovic BD, Su YC, Raisch DW, Ganger D, Belknap SM, Dai MS, Chiu BC, Fintel B, Cheng Y, Chuang SS, Lee MY, Chen TY, Lin SF, Kuo CY. Rituximab-associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-analysis and examination of FDA safety reports. Ann Oncol. 2011;22:1170-1180. [PMID: 21115603 DOI: 10.1093/annonc/mdq583] [Cited by in Crossref: 213] [Cited by in F6Publishing: 184] [Article Influence: 19.4] [Reference Citation Analysis]
70 Nagaraju K, Misra S, Saraswat S, Choudhary N, Masih B, Ramesh V, Naik S. High Prevalence of HBV Infectivity in Blood Donors Detected by the Dot Blot Hybridisation Assay. Vox Sanguinis 1994;67:183-6. [DOI: 10.1111/j.1423-0410.1994.tb01656.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
71 Bréchot C, Kremsdorf D, Paterlini P, Thiers V. Hepatitis B virus DNA in HBsAg-negative patients. Journal of Hepatology 1991;13:S49-55. [DOI: 10.1016/0168-8278(91)90023-5] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 0.8] [Reference Citation Analysis]
72 Michalak TI, Pasquinelli C, Guilhot S, Chisari FV. Hepatitis B virus persistence after recovery from acute viral hepatitis. J Clin Invest. 1994;93:230-239. [PMID: 8282792 DOI: 10.1172/jci116950] [Cited by in Crossref: 205] [Cited by in F6Publishing: 63] [Article Influence: 7.6] [Reference Citation Analysis]
73 Roth WK, Weber M, Petersen D, Drosten C, Buhr S, Sireis W, Weichert W, Hedges D, Seifried E. NAT for HBV and anti-HBc testing increase blood safety. Transfusion. 2002;42:869-875. [PMID: 12375659 DOI: 10.1046/j.1537-2995.2002.00128.x] [Cited by in Crossref: 88] [Cited by in F6Publishing: 83] [Article Influence: 4.6] [Reference Citation Analysis]
74 Scully LJ, Sung H, Pennie R, Gill P. Detection of hepatitis B virus DNA in the serum of Canadian hepatitis B surface antigen negative, anti-HBc positive individuals, using the polymerase chain reaction. J Med Virol 1994;44:293-7. [DOI: 10.1002/jmv.1890440314] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 1.1] [Reference Citation Analysis]
75 Balderas-renterı́a I, Muñoz-espinosa LE, Déctor-carrillo MA, Martı́nez-martı́nez FJ, Barrera-saldaña HA. Detection of Hepatitis B Virus in Seropositive and Seronegative Patients with Chronic Liver Disease Using DNA Amplification by PCR. Archives of Medical Research 2002;33:566-71. [DOI: 10.1016/s0188-4409(02)00391-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
76 Zervou EK, Dalekos GN, Boumba DS, Tsianos EV. Value of anti-HBc screening of blood donors for prevention of HBV infection: results of a 3-year prospective study in Northwestern Greece. Transfusion. 2001;41:652-658. [PMID: 11346702 DOI: 10.1046/j.1537-2995.2001.41050652.x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 56] [Article Influence: 2.8] [Reference Citation Analysis]
77 Motta-castro ARC, Martins RMB, Araujo NM, Niel C, Facholi GB, Lago BV, Mello FCA, Gomes SA. Molecular epidemiology of hepatitis B virus in an isolated Afro-Brazilian community. Arch Virol 2008;153:2197-205. [DOI: 10.1007/s00705-008-0237-0] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 3.0] [Reference Citation Analysis]
78 Bréchot C. Polymerase chain reaction for the diagnosis of hepatitis B and C viral hepatitis. J Hepatol. 1993;17 Suppl 3:S35-S41. [PMID: 8509637 DOI: 10.1016/s0168-8278(05)80421-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
79 Greub G, Frei PC. Presence of low levels of anti-HBs antibody in so-called ‘anti-HBc alone’ subjects: Low anti-HBs levels in anti-Hbc alone subjects. Liver 2001;21:380-3. [DOI: 10.1034/j.1600-0676.2001.210603.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
80 Pollicino T, Squadrito G, Cerenzia G, Cacciola I, Raffa G, Craxi A, Farinati F, Missale G, Smedile A, Tiribelli C, Villa E, Raimondo G. Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection. Gastroenterology. 2004;126:102-110. [PMID: 14699492 DOI: 10.1053/j.gastro.2003.10.048] [Cited by in Crossref: 300] [Cited by in F6Publishing: 286] [Article Influence: 17.6] [Reference Citation Analysis]
81 Eble BE, Corash L. Duck hepatitis B virus inactivation and 8-methoxypsoralen photoadduct formation in human platelet concentrates. Photochem Photobiol. 1998;67:700-713. [PMID: 9648535 DOI: 10.1111/j.1751-1097.1998.tb09475.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
82 Chen CH, Wang JT, Lee CZ, Sheu JC, Wang TH, Chen DS. Quantitative detection of hepatitis B virus DNA in human sera by branched-DNA signal amplification. J Virol Methods 1995;53:131-7. [PMID: 7635922 DOI: 10.1016/0166-0934(95)00007-h] [Cited by in Crossref: 17] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
83 Fang ZL, Zhuang H, Wang XY, Ge XM, Harrison TJ. Hepatitis B virus genotypes, phylogeny and occult infection in a region with a high incidence of hepatocellular carcinoma in China. World J Gastroenterol. 2004;10:3264-3268. [PMID: 15484297 DOI: 10.3748/wjg.v10.i22.3264] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 26] [Article Influence: 1.6] [Reference Citation Analysis]
84 Hwang S, Lee S, Lu R, Chan C, Lai L, Co RL, Tong MJ. Comparison of three different hybridization assays in the quantitative measurement of serum hepatitis B virus DNA. Journal of Virological Methods 1996;62:123-9. [DOI: 10.1016/s0166-0934(96)02093-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
85 Hwang JP, Vierling JM, Zelenetz AD, Lackey SC, Loomba R. Hepatitis B virus management to prevent reactivation after chemotherapy: a review. Support Care Cancer. 2012;20:2999-3008. [PMID: 22933131 DOI: 10.1007/s00520-012-1576-7] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
86 Kim H, Kim BJ. Association of preS/S Mutations with Occult Hepatitis B Virus (HBV) Infection in South Korea: Transmission Potential of Distinct Occult HBV Variants. Int J Mol Sci. 2015;16:13595-13609. [PMID: 26084041 DOI: 10.3390/ijms160613595] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
87 Wang T, Wang J, Lin J, Sheu J, Sung J, Chen D. A prospective study of posttransfusion hepatitis in Taiwan. Journal of Hepatology 1991;13:38-43. [DOI: 10.1016/0168-8278(91)90861-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 0.6] [Reference Citation Analysis]
88 Brechot C, Nalpas B, Feitelson MA. Interactions Between Alcohol and Hepatitis Viruses in the Liver. Clinics in Laboratory Medicine 1996;16:273-87. [DOI: 10.1016/s0272-2712(18)30269-5] [Cited by in Crossref: 31] [Article Influence: 1.2] [Reference Citation Analysis]
89 Makris K, Kouvelis V, Drakopoulos I, Oikonomou E, Maniatis A. Frequency and characteristics of post-transfusion hepatitis in Greece with emphasis on hepatitis C: comparing second- and third-generation assays. Transfus Med 1995;5:213-24. [PMID: 8593527 DOI: 10.1111/j.1365-3148.1995.tb00231.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.3] [Reference Citation Analysis]
90 Ha J, Park Y, Kim HS. Evaluation of clinical sensitivity and specificity of hepatitis B virus (HBV), hepatitis C virus, and human immunodeficiency Virus-1 by cobas MPX: Detection of occult HBV infection in an HBV-endemic area. J Clin Virol 2017;96:60-3. [PMID: 28982042 DOI: 10.1016/j.jcv.2017.09.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
91 Weber B, Dengler T, Berger A, Doerr HW, Rabenau H. Evaluation of two new automated assays for hepatitis B virus surface antigen (HBsAg) detection: IMMULITE HBsAg and IMMULITE 2000 HBsAg. J Clin Microbiol. 2003;41:135-143. [PMID: 12517838 DOI: 10.1128/jcm.41.1.135-143.2003] [Cited by in Crossref: 40] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
92 Hou J, Karayiannis P, Waters J, Luo K, Liang C, Thomas HC. A unique insertion in theS gene of surface antigen–negative hepatitis B virus Chinese carriers. Hepatology 1995;21:273-8. [DOI: 10.1002/hep.1840210202] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
93 Dusheiko G, Xu J, Zuckermann AJ. Clinical Diagnosis of Hepatitis B Infection: Applications of the Polymerase Chain Reaction. In: Becker Y, Darai G, editors. Diagnosis of Human Viruses by Polymerase Chain Reaction Technology. Berlin: Springer Berlin Heidelberg; 1992. pp. 67-85. [DOI: 10.1007/978-3-642-84766-0_7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
94 Wang JT, Wang T, Sheu J, Lin J, Wang C, Chen D. Posttransfusion hepatitis revisited by hepatitis C antibody assays and polymerase chain reaction. Gastroenterology 1992;103:609-16. [DOI: 10.1016/0016-5085(92)90854-r] [Cited by in Crossref: 22] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
95 Wang L, Chang L, Xie Y, Huang C, Xu L, Qian R, Zhu H, He Y, Li J, Huang H, Li W, Zhang K, Zhang R, Xie J, Sun Y, Li J. What is the meaning of a nonresolved viral nucleic acid test-reactive minipool? Transfusion 2015;55:395-404. [PMID: 25125223 DOI: 10.1111/trf.12818] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
96 Jilg W, Sieger E, Zachoval R, Schätzl H. Individuals with antibodies against hepatitis B core antigen as the only serological marker for hepatitis B infection: high percentage of carriers of hepatitis B and C virus. J Hepatol. 1995;23:14-20. [PMID: 8530804 DOI: 10.1016/0168-8278(95)80305-x] [Cited by in Crossref: 120] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
97 Barbara JA, Garson JA. Polymerase Chain Reaction and Transfusion Microbiology. Vox Sanguinis 1993;64:73-81. [DOI: 10.1111/j.1423-0410.1993.tb02522.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
98 Wang JT, Lee CZ, Chen PJ, Wang TH, Chen DS. Transfusion-transmitted HBV infection in an endemic area: the necessity of more sensitive screening for HBV carriers. Transfusion. 2002;42:1592-1597. [PMID: 12473140 DOI: 10.1046/j.1537-2995.2002.00274.x] [Cited by in Crossref: 60] [Cited by in F6Publishing: 51] [Article Influence: 3.3] [Reference Citation Analysis]
99 Silva CM, Costi C, Costa C, Michelon C, Oravec R, Ramos AB, Niel C, Rossetti ML. Low rate of occult hepatitis B virus infection among anti-HBc positive blood donors living in a low prevalence region in Brazil. J Infect 2005;51:24-9. [PMID: 15979486 DOI: 10.1016/j.jinf.2004.07.007] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 1.1] [Reference Citation Analysis]
100 Seelig R, Renz M, Seelig HP. PCR in the Diagnosis of Viral Hepatitis. Annals of Medicine 2009;24:225-30. [DOI: 10.3109/07853899209147827] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
101 Foster CE 3rd, Philosophe B, Schweitzer EJ, Colonna JO, Farney AC, Jarrell B, Anderson L, Bartlett ST. A decade of experience with renal transplantation in African-Americans. Ann Surg 2002;236:794-804; discussion 804-805. [PMID: 12454518 DOI: 10.1097/00000658-200212000-00012] [Cited by in Crossref: 57] [Cited by in F6Publishing: 48] [Article Influence: 3.2] [Reference Citation Analysis]
102 Wang JT, Wang TH, Sheu JC, Lin SM, Lin JT, Chen DS. Effects of anticoagulants and storage of blood samples on efficacy of the polymerase chain reaction assay for hepatitis C virus. J Clin Microbiol 1992;30:750-3. [PMID: 1313053 DOI: 10.1128/jcm.30.3.750-753.1992] [Cited by in Crossref: 92] [Cited by in F6Publishing: 23] [Article Influence: 3.2] [Reference Citation Analysis]
103 Rodríguez-Méndez ML, González-Quintela A, Aguilera A, Barrio E. Prevalence, patterns, and course of past hepatitis B virus infection in intravenous drug users with HIV-1 infection. Am J Gastroenterol. 2000;95:1316-1322. [PMID: 10811346 DOI: 10.1111/j.1572-0241.2000.01981.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 35] [Article Influence: 2.0] [Reference Citation Analysis]
104 Fang Y, Shang Q, Liu J, Li D, Xu W, Teng X, Zhao H, Fu L, Zhang F, Gu H. Prevalence of occult hepatitis B virus infection among hepatopathy patients and healthy people in China. Journal of Infection 2009;58:383-8. [DOI: 10.1016/j.jinf.2009.02.013] [Cited by in Crossref: 54] [Cited by in F6Publishing: 61] [Article Influence: 4.5] [Reference Citation Analysis]